| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $33,625,850 ) (Continued on the next page) |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM131832 | Molecular Mechanisms of Mitochondrial Transcription and Replication | 000 | 8 | NIH | 5/19/2026 | $544,190 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01EY035772 | Solute Transporters and Retinal Health | 000 | 2 | NIH | 5/5/2026 | $581,302 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL140064 | Biased Muscarinic Acetylcholine Receptor Signaling in Obstructive Lung Disease Pathology and Therapy | 001 | 7 | NIH | 3/25/2026 | $17,853 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL140064 | Biased Muscarinic Acetylcholine Receptor Signaling in Obstructive Lung Disease Pathology and Therapy | 000 | 7 | NIH | 2/9/2026 | $565,367 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01EY026478 | Regulatory role of PI3K signaling pathways in lens differentiation and function | 001 | 11 | NIH | 6/1/2026 | $442,059 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01EY021784 | Paradigms of maintaining anterior segment homeostasis | 000 | 15 | NIH | 4/6/2026 | $572,513 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM156956 | Elucidating the mechanisms underlying DNA double-strand break repair | 001 | 2 | NIH | 3/13/2026 | $39,000 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM156956 | Elucidating the mechanisms underlying DNA double-strand break repair | 000 | 2 | NIH | 2/5/2026 | $351,000 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HD112076 | Dose based aspirin pharmacokinetics and pharmacodynamics in pregnancy and association with pregnancy outcomes | 001 | 2 | NIH | 4/1/2026 | $66,336 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HD112076 | Dose based aspirin pharmacokinetics and pharmacodynamics in pregnancy and association with pregnancy outcomes | 000 | 2 | NIH | 12/30/2025 | $597,034 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01GM144553 | Crosstalk between DNA repair pathways in repeat instability | 001 | 4 | NIH | 3/11/2026 | $31,200 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01GM144553 | Crosstalk between DNA repair pathways in repeat instability | 000 | 4 | NIH | 12/31/2025 | $280,800 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R37CA234239 | Tumor Microenvironment Metabolism in Invasive Ductal Carcinoma of the Breast | 002 | 7 | NIH | 4/16/2026 | $35,684 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R37CA234239 | Tumor Microenvironment Metabolism in Invasive Ductal Carcinoma of the Breast | 001 | 7 | NIH | 2/19/2026 | $29,073 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R37CA234239 | Tumor Microenvironment Metabolism in Invasive Ductal Carcinoma of the Breast | 000 | 7 | NIH | 12/5/2025 | $292,093 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI175567 | Mechanisms of protective memory CD8 T-cell induction by mRNA-LNP vaccines | 000 | 4 | NIH | 5/26/2026 | $166,684 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI175567 | Mechanisms of protective memory CD8 T-cell induction by mRNA-LNP vaccines | 000 | 4 | NIH | 5/26/2026 | $542,053 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL172942 | Short inhibitory RNAs in platelet and megakaryocyte function | 001 | 2 | NIH | 3/24/2026 | $16,573 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01MH138995 | Pathophysiologic roles of protein-protein interactions at excitatory synapses and their modifications in schizophrenia | 000 | 2 | NIH | 12/10/2025 | $671,768 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA284017 | Deciphering the role of NELFE in modulating MYC signaling in HCC | 000 | 4 | NIH | 6/3/2026 | $356,850 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01EY035771 | Molecular function of extracellular vimentin in regulating the response to lens wounding | 000 | 3 | NIH | 5/7/2026 | $450,118 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL173113 | Allosteric modulation of beta2- adrenoceptors in the treatment of asthma | 000 | 3 | NIH | 4/27/2026 | $555,192 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI156384 | Role of IL-7R in CNS autoimmunity | 000 | 5 | NIH | 1/22/2026 | $390,000 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA268899 | A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | 001 | 5 | NIH | 4/16/2026 | $54,001 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA268899 | A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | 000 | 5 | NIH | 12/18/2025 | $486,021 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21NS145175 | Early Detection of Respiratory Impairments in ALS: A Novel Diagnostic Approach | 000 | 1 | NIH | 6/8/2026 | $196,250 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR082460 | The role of endogenous low molecular weight mineralization inhibitors in spine health | 000 | 3 | NIH | 12/11/2025 | $615,468 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | T2554964 | Addiction Medicine Fellowship | 00 | 2 | HRSA | 5/27/2026 | $600,000 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR082460 | The role of endogenous low molecular weight mineralization inhibitors in spine health | 001 | 3 | NIH | 5/14/2026 | $34,193 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL173436 | Platelets as regulator of non-neurological complications of ischemic stroke | 000 | 2 | NIH | 5/18/2026 | $764,352 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AG078609 | Promoting regenerative repair of aged cartilage | 000 | 4 | NIH | 1/22/2026 | $696,444 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AG078609 | Promoting regenerative repair of aged cartilage | 001 | 4 | NIH | 2/25/2026 | $77,382 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS132056 | Mitochondrial Calcium and Neuronal Health | 000 | 4 | NIH | 6/3/2026 | $623,535 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK136992 | Hypercalciuria and Abnormal Bone in the Genetic Hypercalciuric Stone-Forming Rats | 000 | 3 | NIH | 1/23/2026 | $456,524 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01ES034077 | The Role of m6A-RNA Methylation in Memory Formation and Recall and Its Modulation and Influence on Long-Term Outcomes as a Consequence of Early Life Lead Exposure | 001 | 4 | NIH | 5/4/2026 | $575,373 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DE033025 | Investigating a new vulnerability in oral squamous cell carcinoma | 000 | 4 | NIH | 5/12/2026 | $521,948 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01ES033197 | METTL3 in chromium-induced angiogenesis and carcinogenesis | 000 | 5 | NIH | 1/22/2026 | $519,475 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA267549 | WNT pathway-driven anti-estrogen therapy resistance in breast cancer | 000 | 4 | NIH | 5/5/2026 | $564,048 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM147191 | From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors | 000 | 5 | NIH | 4/24/2026 | $390,000 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA262570 | Pharmacological Jak2 inhibition to overcome androgen receptor aberrations in prostate cancer | 000 | 5 | NIH | 3/30/2026 | $591,355 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA263506 | MiR-152/PKM2/SLC7A5 axis in breast cancer development, chemo- and radiation-treatment response | 000 | 5 | NIH | 3/30/2026 | $644,810 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | T32GM144302 | Training Grant in Cellular, Biochemical and Molecular Sciences | 000 | 5 | NIH | 5/25/2026 | $323,493 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI190368 | Trained Immunity Induced by mRNA-LNP | 000 | 1 | NIH | 2/19/2026 | $813,921 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21CA303372 | Microbubble augmentation of immunotherapy in head and neck cancer | 000 | 1 | NIH | 6/8/2026 | $401,115 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21MH138289 | DNA-PK impact on HIV reservoir in the CNS | 000 | 1 | NIH | 5/18/2026 | $431,750 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | P01CA298993 | Neuroendocrine Prostate Cancer Progression and Novel Therapeutic Vulnerabilities | 000 | 1 | NIH | 4/27/2026 | $1,656,379 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F31CA309862 | Bi-functional degrader with treatment potential for B-cell lymphoma | 000 | 1 | NIH | 5/13/2026 | $50,114 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21DA065026 | Xylazine, Pregnancy, and Access to Care | 001 | 1 | NIH | 4/7/2026 | $0 |
| | 2026 | 2026 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21DA065026 | Xylazine, Pregnancy, and Access to Care | 000 | 1 | NIH | 2/12/2026 | $346,500 |
|
